BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 28156019)

  • 41. [Psoriasis: a systemic disease].
    Bens G; Maccari F; Estève E
    Presse Med; 2012 Apr; 41(4):338-48. PubMed ID: 22136910
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Amphiregulin enhances VEGF-A production in human chondrosarcoma cells and promotes angiogenesis by inhibiting miR-206 via FAK/c-Src/PKCδ pathway.
    Wang CQ; Huang YW; Wang SW; Huang YL; Tsai CH; Zhao YM; Huang BF; Xu GH; Fong YC; Tang CH
    Cancer Lett; 2017 Jan; 385():261-270. PubMed ID: 27826039
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Vascular endothelial growth factor, vascular endothelial growth factor receptor-3 and cyclooxygenase-2 expression in psoriasis.
    Yalçin B; Tezel GG; Arda N; Erman M; Alli N
    Anal Quant Cytol Histol; 2007 Dec; 29(6):358-64. PubMed ID: 18225391
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Influence of vascular endothelial growth factor on angiogenesis and neurogenesis].
    Rud'ko AS; Efendieva MK; Budzinskaya MV; Karpilova MA
    Vestn Oftalmol; 2017; 133(3):75-81. PubMed ID: 28745660
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Psoriasin (S100A7) promotes stress-induced angiogenesis.
    Vegfors J; Ekman AK; Stoll SW; Bivik Eding C; Enerbäck C
    Br J Dermatol; 2016 Dec; 175(6):1263-1273. PubMed ID: 27155199
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Angiogenesis--a new target for future therapy.
    Pandya NM; Dhalla NS; Santani DD
    Vascul Pharmacol; 2006 May; 44(5):265-74. PubMed ID: 16545987
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Sequential Functions of CPEB1 and CPEB4 Regulate Pathologic Expression of Vascular Endothelial Growth Factor and Angiogenesis in Chronic Liver Disease.
    Calderone V; Gallego J; Fernandez-Miranda G; Garcia-Pras E; Maillo C; Berzigotti A; Mejias M; Bava FA; Angulo-Urarte A; Graupera M; Navarro P; Bosch J; Fernandez M; Mendez R
    Gastroenterology; 2016 Apr; 150(4):982-97.e30. PubMed ID: 26627607
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Inhibition of vascular endothelial growth factor with shRNA in chondrocytes ameliorates osteoarthritis.
    Zhang X; Crawford R; Xiao Y
    J Mol Med (Berl); 2016 Jul; 94(7):787-98. PubMed ID: 27164955
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A new selective vascular endothelial growth factor receptor 2 inhibitor ablates disease in a mouse model of psoriasis.
    Yan HX; Wang Y; Yang XN; Fu LX; Tang DM
    Mol Med Rep; 2013 Aug; 8(2):434-8. PubMed ID: 23732650
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Ganglioside GM3 inhibits VEGF/VEGFR-2-mediated angiogenesis: direct interaction of GM3 with VEGFR-2.
    Chung TW; Kim SJ; Choi HJ; Kim KJ; Kim MJ; Kim SH; Lee HJ; Ko JH; Lee YC; Suzuki A; Kim CH
    Glycobiology; 2009 Mar; 19(3):229-39. PubMed ID: 18974200
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Psoriasis and atherosclerosis: Is there a need for novel biomarkers assessing cardiovascular risk?
    Sunbul M; Agirbasli M
    Curr Pharm Des; 2014; 20(4):529-35. PubMed ID: 23565636
    [TBL] [Abstract][Full Text] [Related]  

  • 52. From the cradle to the clinic: VEGF in developmental, physiological, and pathological angiogenesis.
    Harry LE; Paleolog EM
    Birth Defects Res C Embryo Today; 2003 Nov; 69(4):363-74. PubMed ID: 14745976
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Vascular endothelial growth factor as a survival factor in tumor-associated angiogenesis.
    Affara NI; Robertson FM
    In Vivo; 2004; 18(5):525-42. PubMed ID: 15523889
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Basic fibroblast growth factor induces VEGF expression in chondrosarcoma cells and subsequently promotes endothelial progenitor cell-primed angiogenesis.
    Tzeng HE; Chen PC; Lin KW; Lin CY; Tsai CH; Han SM; Teng CL; Hwang WL; Wang SW; Tang CH
    Clin Sci (Lond); 2015 Jul; 129(2):147-58. PubMed ID: 25735814
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Lentivirus-mediated shRNA interference targeting vascular endothelial growth factor inhibits angiogenesis and progression of human pancreatic carcinoma.
    Zhao X; Zhu DM; Gan WJ; Li Z; Zhang JL; Zhao H; Zhou J; Li DC
    Oncol Rep; 2013 Mar; 29(3):1019-26. PubMed ID: 23254994
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Vascular endothelial growth factor partially induces pruritus via epidermal hyperinnervation in imiquimod-induced psoriasiform dermatitis in mice.
    Wong LS; Otsuka A; Yamamoto Y; Nonomura Y; Nakashima C; Honda T; Dainichi T; Kitoh A; Nakajima S; Hirakawa S; Miyachi Y; Kabashima K
    J Dermatol Sci; 2016 Aug; 83(2):148-51. PubMed ID: 27156794
    [No Abstract]   [Full Text] [Related]  

  • 57. Elevated Gab2 induces tumor growth and angiogenesis in colorectal cancer through upregulating VEGF levels.
    Ding C; Luo J; Fan X; Li L; Li S; Wen K; Feng J; Wu G
    J Exp Clin Cancer Res; 2017 Apr; 36(1):56. PubMed ID: 28420432
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Vascular endothelial growth factor--structure and functions].
    Barańska P; Jerczyńska H; Pawłowska Z
    Postepy Biochem; 2005; 51(1):12-21. PubMed ID: 16209337
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Activation of fractalkine/CX3CR1 by vascular endothelial cells induces angiogenesis through VEGF-A/KDR and reverses hindlimb ischaemia.
    Ryu J; Lee CW; Hong KH; Shin JA; Lim SH; Park CS; Shim J; Nam KB; Choi KJ; Kim YH; Han KH
    Cardiovasc Res; 2008 May; 78(2):333-40. PubMed ID: 18006432
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [The role of vascular endothelial growth factor in angiogenesis and diabetic retinopathy].
    Valiatti FB; Crispim D; Benfica C; Valiatti BB; Kramer CK; Canani LH
    Arq Bras Endocrinol Metabol; 2011 Mar; 55(2):106-13. PubMed ID: 21584427
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.